Intrathecal administration of botulinum toxin type a antagonizes neuropathic pain by countering increased vesicular nucleotide transporter expression in the spinal cord of chronic constriction injury of the sciatic nerve rats-Reference-Cited by-同舟云学术

Intrathecal administration of botulinum toxin type a antagonizes neuropathic pain by countering increased vesicular nucleotide transporter expression in the spinal cord of chronic constriction injury of the sciatic nerve rats

Published:2023-08 Issue: Volume:100 Page:102346
ISSN:0143-4179
Container-title:Neuropeptides
language:en
Short-container-title:Neuropeptides

Author:

Shi Yongqiang,Gong Chaoyang,Nan Wei,Zhou Wenming,Lei Zeyuan,Zhou Kaisheng,Wang Linna,Zhao Guanghai,Zhang Haihong

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Endocrine and Autonomic Systems,Neurology,Endocrinology,General Medicine

Reference48 articles.

1. A novel strain of clostridium botulinum that produces type B and type H botulinum toxins;Barash;J. Infect. Dis.,2014

2. ATP release during seizures - a critical evaluation of the evidence;Beamer;Brain Res. Bull.,2019

3. Purine and purinergic receptors;Burnstock;Brain Neurosci. Adv.,2018

4. Function and mechanisms of truncated BDNF receptor TrkB.T1 in neuropathic pain;Cao;Cells,2020

5. Quantitative assessment of tactile allodynia in the rat paw;Chaplan;J. Neurosci. Methods,1994

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Botulinum toxin type A is a potential therapeutic drug for chronic orofacial pain;Journal of Oral Biosciences;2024-09

2. Neurobiological mechanisms of botulinum neurotoxin-induced analgesia for neuropathic pain;Pharmacology & Therapeutics;2024-07

3. Effect and mechanism of action of botulinum toxin type A on hypertrophic scar <i>in vitro</i>;Tropical Journal of Pharmaceutical Research;2024-01-10

4. Molecular mechanisms of pain in acute pancreatitis: recent basic research advances and therapeutic implications;Frontiers in Molecular Neuroscience;2023-12-22

5. Role and therapeutic target of P2X2/3 receptors in visceral pain;Neuropeptides;2023-10